Grifols, S.A. (BME:GRF)
10.67
+0.01 (0.09%)
Nov 17, 2025, 12:14 PM CET
Grifols Revenue
Grifols had revenue of 1.87B EUR in the quarter ending September 30, 2025, with 4.04% growth. This brings the company's revenue in the last twelve months to 7.52B, up 7.31% year-over-year. In the year 2024, Grifols had annual revenue of 7.21B with 9.41% growth.
Revenue (ttm)
7.52B
Revenue Growth
+7.31%
P/S Ratio
0.86
Revenue / Employee
315.89K
Employees
23,833
Market Cap
6.46B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 7.21B | 620.41M | 9.41% |
| Dec 31, 2023 | 6.59B | 528.01M | 8.71% |
| Jan 1, 2023 | 6.06B | 1.13B | 22.92% |
| Dec 31, 2021 | 4.93B | -406.92M | -7.62% |
| Dec 31, 2020 | 5.34B | 241.35M | 4.73% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Almirall | 1.09B |
| Laboratorios Farmaceuticos Rovi | 724.20M |
| Faes Farma | 571.12M |
| Laboratorio Reig Jofre | 330.34M |
| Clínica Baviera | 288.92M |
| Prim, S.A. | 240.68M |
| Atrys Health | 226.24M |
| Pharma Mar | 179.28M |
Grifols News
- 11 days ago - Grifols, S.A. (GIKLY) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 12 days ago - Q3 2025 Grifols SA Earnings Call Transcript - GuruFocus
- 12 days ago - Grifols, S.A. 2025 Q3 - Results - Earnings Call Presentation - Seeking Alpha
- 12 days ago - Top Biotech Stocks Riding The Rally - Seeking Alpha
- 12 days ago - Grifols (GRFS) Sees Revenue Boost from Biopharma Sector - GuruFocus
- 17 days ago - 4 Best Value And Growth Stocks (Yes, They Can Coexist) - Seeking Alpha
- 20 days ago - Are Investors Undervaluing Grifols (GRFS) Right Now? - Nasdaq
- 5 weeks ago - Spanish court summons Gotham City founder in Grifols share price probe - Reuters